K. Trerayapiwat

Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand

P. Sritara, N. Chaiyakunapruk, S. Nathisuwan, 2022, The Lancet regional health. Western Pacific.

Meropenem Pharmacokinetics During the Initial Phase of Life-Threatening Infections in Critically Ill Patients in Intensive Care Units

S. Sriwiriyajan, S. Jaruratanasirikul, Monchana Nawakitrangson, 2019, Pharmaceutical Sciences Asia.